Implicit Bioscience owns all rights to this first-in-class monoclonal antibody. Implicit Bioscience operates as a clinical-stage drug development company. It applies breakthrough discoveries in immunology to make transformational changes to the way they manage inflammatory and infectious diseases.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.